A treatable early onset epileptic encephalopathy: pyridoxamine 5'-phosphate oxidase deficiency

Authors

  • Sai C. Dudipala Department of Pediatric Neurology, Star Women and Children Hospital, Karimnagar, Telangana, India https://orcid.org/0000-0002-1988-6097
  • Sagar Potharajula Department of Pediatrics, Star Women and Children Hospital, Karimnagar, Telangana, India
  • Srikanth R. Pabbathi Department of Pediatrics, Star Women and Children Hospital, Karimnagar, Telangana, India
  • Krishna Chaithanya Battu Department of Pediatrics, Star Women and Children Hospital, Karimnagar, Telangana, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20241688

Keywords:

PNPO deficiency, Epileptic encephalopathy, Pyridoxine, Vitamin responsive epilepsy

Abstract

Pyridox (am) ine 5'-phosphate oxidase (PNPO) deficiency is a rare epileptic encephalopathy condition due to mutations in PNPO gene. It is one of treatable metabolic epilepsies. It is unresponsive to antiseizure medications, but respond to pyridoxal-5-phosphate (PLP), active form of vitamin B6. It is characterized by refractory seizures from newborn or in utero, developmental delay. Based on refractory seizures, age of onset, negative biochemical profile and response to PLP, suspect PNPO deficiency. Next generation sequencing will help in the diagnosis. Early diagnosis and early initiation of PLP will help to cessation of seizures and better neurological outcome. Here we present a case of PNPO deficiency, which is diagnosed early and noticed good response with PLP.

References

Sharma S, Prasad AN. Inborn Errors of Metabolism and Epilepsy: Current Understanding, Diagnosis, and Treatment Approaches. Int J Mol Sci. 2017;2:1384.

Mills PB, Surtees RA, Champion MP, Beesley CE, Dalton N, Scambler PJ, et al. Neonatal epileptic encephalopathy caused by mutations in the PNPO gene encoding pyridox(am)ine 5'-phosphate oxidase. Hum Mol Genet. 2005;14(8):1077-86.

Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross H, Boas WVE, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676-85.

Bairoch A. The ENZYME database in 2000. Nucleic Acids Res. 2000;28(1):304-5.

Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res. 2011;39(Database issue):D52-7.

Bräutigam C, Hyland K, Wevers R, Sharma R, Wagner L, Stock GJ, et al. Clinical and laboratory findings in twins with neonatal epileptic encephalopathy mimicking aromatic L-amino acid decarboxylase deficiency. Neuropediatrics. 2002;33(3):113-7.

Plecko B, Mills P. PNPO Deficiency. Adam MP, Feldman J, Mirzaa GM, editors. GeneReviews, Seattle. 2022.

Alghamdi M, Bashiri FA, Abdelhakim M, Adly N, Jamjoom DZ, Sumaily KM, et al. Phenotypic and molecular spectrum of pyridoxamine-5'-phosphate oxidase deficiency: A scoping review of 87 cases of pyridoxamine-5'-phosphate oxidase deficiency. Clin Genet. 2021;99(1):99-110.

Xue J, Chang X, Zhang Y, Yang Z. Novel phenotypes of pyridox(am)ine-5'-phosphate oxidase deficiency and high prevalence of c.445_448del mutation in Chinese patients. Metab Brain Dis. 2017;32(4):1081-7.

Downloads

Published

2024-06-26

Issue

Section

Case Reports